Schedule shifts, cancer and longevity

Good, bad or indifferent?

Germaine G Cornelissen-Guillaume, Julia Halberg, Franz Halberg, Salvador Sanchez De La Pena, Walter Nelson, Othild Schwartzkopff, Alexander Stoynev, Erhard Haus

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

Prompted by a recent report of the possible carcinogenic effect of shiftwork focusing on the disruption of circadian rhythms, we review studies involving shifts in schedule implemented at varying intervals in unicells, insects and mammals, including humans. Results indicate the desirability to account for a broader-than-circadian view. They also suggest the possibility of optimizing schedule shifts by selecting intervals between consecutive shifts associated with potential side-effects such as an increase in cancer risk. Toward this goal, marker rhythmometry is most desirable. The monitoring of blood pressure and heart rate present the added benefit of assessing cardiovascular disease risks resulting not only from an elevated blood pressure but also from abnormal variability in blood pressure and/or heart rate of normotensive as well as hypertensive subjects.

Original languageEnglish (US)
Pages (from-to)263-273
Number of pages11
JournalJournal of Experimental Therapeutics and Oncology
Volume7
Issue number4
StatePublished - Dec 1 2008

Fingerprint

Appointments and Schedules
Blood Pressure
Heart Rate
Neoplasms
Circadian Rhythm
Insects
Mammals
Cardiovascular Diseases

Cite this

Cornelissen-Guillaume, G. G., Halberg, J., Halberg, F., De La Pena, S. S., Nelson, W., Schwartzkopff, O., ... Haus, E. (2008). Schedule shifts, cancer and longevity: Good, bad or indifferent? Journal of Experimental Therapeutics and Oncology, 7(4), 263-273.

Schedule shifts, cancer and longevity : Good, bad or indifferent? / Cornelissen-Guillaume, Germaine G; Halberg, Julia; Halberg, Franz; De La Pena, Salvador Sanchez; Nelson, Walter; Schwartzkopff, Othild; Stoynev, Alexander; Haus, Erhard.

In: Journal of Experimental Therapeutics and Oncology, Vol. 7, No. 4, 01.12.2008, p. 263-273.

Research output: Contribution to journalReview article

Cornelissen-Guillaume, GG, Halberg, J, Halberg, F, De La Pena, SS, Nelson, W, Schwartzkopff, O, Stoynev, A & Haus, E 2008, 'Schedule shifts, cancer and longevity: Good, bad or indifferent?', Journal of Experimental Therapeutics and Oncology, vol. 7, no. 4, pp. 263-273.
Cornelissen-Guillaume GG, Halberg J, Halberg F, De La Pena SS, Nelson W, Schwartzkopff O et al. Schedule shifts, cancer and longevity: Good, bad or indifferent? Journal of Experimental Therapeutics and Oncology. 2008 Dec 1;7(4):263-273.
Cornelissen-Guillaume, Germaine G ; Halberg, Julia ; Halberg, Franz ; De La Pena, Salvador Sanchez ; Nelson, Walter ; Schwartzkopff, Othild ; Stoynev, Alexander ; Haus, Erhard. / Schedule shifts, cancer and longevity : Good, bad or indifferent?. In: Journal of Experimental Therapeutics and Oncology. 2008 ; Vol. 7, No. 4. pp. 263-273.
@article{dae63c2f13ee47a090a5656585629b99,
title = "Schedule shifts, cancer and longevity: Good, bad or indifferent?",
abstract = "Prompted by a recent report of the possible carcinogenic effect of shiftwork focusing on the disruption of circadian rhythms, we review studies involving shifts in schedule implemented at varying intervals in unicells, insects and mammals, including humans. Results indicate the desirability to account for a broader-than-circadian view. They also suggest the possibility of optimizing schedule shifts by selecting intervals between consecutive shifts associated with potential side-effects such as an increase in cancer risk. Toward this goal, marker rhythmometry is most desirable. The monitoring of blood pressure and heart rate present the added benefit of assessing cardiovascular disease risks resulting not only from an elevated blood pressure but also from abnormal variability in blood pressure and/or heart rate of normotensive as well as hypertensive subjects.",
author = "Cornelissen-Guillaume, {Germaine G} and Julia Halberg and Franz Halberg and {De La Pena}, {Salvador Sanchez} and Walter Nelson and Othild Schwartzkopff and Alexander Stoynev and Erhard Haus",
year = "2008",
month = "12",
day = "1",
language = "English (US)",
volume = "7",
pages = "263--273",
journal = "Journal of experimental therapeutics & oncology",
issn = "1359-4117",
publisher = "Old City Publishing",
number = "4",

}

TY - JOUR

T1 - Schedule shifts, cancer and longevity

T2 - Good, bad or indifferent?

AU - Cornelissen-Guillaume, Germaine G

AU - Halberg, Julia

AU - Halberg, Franz

AU - De La Pena, Salvador Sanchez

AU - Nelson, Walter

AU - Schwartzkopff, Othild

AU - Stoynev, Alexander

AU - Haus, Erhard

PY - 2008/12/1

Y1 - 2008/12/1

N2 - Prompted by a recent report of the possible carcinogenic effect of shiftwork focusing on the disruption of circadian rhythms, we review studies involving shifts in schedule implemented at varying intervals in unicells, insects and mammals, including humans. Results indicate the desirability to account for a broader-than-circadian view. They also suggest the possibility of optimizing schedule shifts by selecting intervals between consecutive shifts associated with potential side-effects such as an increase in cancer risk. Toward this goal, marker rhythmometry is most desirable. The monitoring of blood pressure and heart rate present the added benefit of assessing cardiovascular disease risks resulting not only from an elevated blood pressure but also from abnormal variability in blood pressure and/or heart rate of normotensive as well as hypertensive subjects.

AB - Prompted by a recent report of the possible carcinogenic effect of shiftwork focusing on the disruption of circadian rhythms, we review studies involving shifts in schedule implemented at varying intervals in unicells, insects and mammals, including humans. Results indicate the desirability to account for a broader-than-circadian view. They also suggest the possibility of optimizing schedule shifts by selecting intervals between consecutive shifts associated with potential side-effects such as an increase in cancer risk. Toward this goal, marker rhythmometry is most desirable. The monitoring of blood pressure and heart rate present the added benefit of assessing cardiovascular disease risks resulting not only from an elevated blood pressure but also from abnormal variability in blood pressure and/or heart rate of normotensive as well as hypertensive subjects.

UR - http://www.scopus.com/inward/record.url?scp=58649089762&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58649089762&partnerID=8YFLogxK

M3 - Review article

VL - 7

SP - 263

EP - 273

JO - Journal of experimental therapeutics & oncology

JF - Journal of experimental therapeutics & oncology

SN - 1359-4117

IS - 4

ER -